Sitagliptin phosphate

Details

Files
Generic Name:
Sitagliptin phosphate
Project Status:
Complete
Therapeutic Area:
Diabetes mellitus (Type 2)
Manufacturer:
Merck Frosst Canada Ltd.
Brand Name:
Januvia
Project Line:
Reimbursement Review
Project Number:
SR0122-000
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Diabetes mellitus (Type 2)
Recommendation Type:
Do not list
Final Recommendation: